Microvascular Therapeutics receives $3.98M Award from CDMRP
- MVT
- Oct 24, 2023
- 0 min read
top of page
Search
Recent Posts
See AllSalt Lake City, UT – July 13, 2025 – Microvascular Therapeutics (MVT), a pioneering Utah based biotechnology company, is thrilled to...
Boston, MA – June 18, 2025 – Microvascular Therapeutics (MVT) is pleased to announce Founder and CEO, Dr. Evan Unger, as speaker on the...
May 14th, 2025 Salt Lake City, Utah: Microvascular Therapeutics, Inc. (MVT), a biotechnology company, announced that it has completed...
bottom of page
Commentaires